GJB6 (Gap junction beta-6 protein) variants and mutations
GJB6 (also known as Gap junction beta-6 protein) is a human protein-coding gene encoding a gap junction beta-6 protein. It forms connexin 30 gap junctions in the cochlea, skin, and other epithelia and contributes to intercellular ion and metabolite exchange. Deletions or pathogenic variants can cause nonsyndromic hearing loss or ectodermal dysplasia syndromes. This analysis covers 639 GJB6 variants and mutations. Of these, 93% have computational variant effect predictions. Disease context includes Clouston syndrome, autosomal recessive nonsyndromic hearing loss 1B, and autosomal dominant nonsyndromic hearing loss 3B. Example GJB6 variants include M1?, M1V, and D2N.
Variant analysis overview
- Gene: GJB6
- Protein: Gap junction beta-6 protein
- UniProt accession: O95452
- Organism: Homo sapiens
- Variants analyzed: 639
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 347 unspecified-consequence records; 1 stop retained variant; 120 missense variants; 126 synonymous variants; 27 frameshift variants; 6 in-frame deletions; 2 in-frame insertions; 8 stop-gained variants; 3 substitution
- Prediction scores: 592 variants have prediction scores (93% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Clouston syndrome, autosomal recessive nonsyndromic hearing loss 1B, autosomal dominant nonsyndromic hearing loss 3B, hearing loss, autosomal recessive, autosomal recessive nonsyndromic hearing loss 1A, X-linked hypohidrotic ectodermal dysplasia, neurodegenerative disease, X-linked mixed deafness with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher, autosomal dominant nonsyndromic hearing loss, KID syndrome, Palmoplantar hyperkeratosis.
Protein structure and variant hotspots
- Protein features: 4 transmembrane segments.
- Structural context: 233 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable GJB6 variants
Examples include M1?, M1V, D2N, p.Asp2 Trp3insThrThrTyrGlnSerIle, D2D, D2A, W3*, G4G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV53833
- M1V (p.Met1Val), rs776848994, ClinGen CA6904530, ClinVar RCV000578760, Uncertain significance, not provided
- D2N (p.Asp2Asn), cosmic curated COSV53833, MetaLR 0.91, MetaSVM 0.75
- p.Asp2 Trp3insThrThrTyrGlnSerIle, gnomAD 13-20223474-A-AGG, CADD 26.00
- D2D (p.Asp2Asp), rs200415730, gnomAD 13-20223475-A-G, CADD 1.82
- D2A (p.Asp2Ala), gnomAD 13-20223476-T-G, MetaLR 0.94, MetaSVM 1.15
- W3* (p.Trp3Ter), gnomAD 13-20223472-C-T, CADD 36.00
- G4G (p.Gly4Gly), rs1486577990, gnomAD 13-20223469-C-T, CADD 1.88
- G4R (p.Gly4Arg), gnomAD 13-20223471-C-T, MetaLR 0.90, MetaSVM 0.88
- T5M (p.Thr5Met), rs104894414, ClinGen CA267609, NCI-TCGA Cosmic COSV5383, cosmic curated COSV53831, CADD 15.20, PolyPhen-2 0.93, Pathogenic, Autosomal dominant nonsyndromic hearing loss 3B
- T5T (p.Thr5Thr), rs150075979, gnomAD 13-20223466-C-A, CADD 0.85
- T5S (p.Thr5Ser), gnomAD 13-20223468-T-A, MetaLR 0.82, MetaSVM 0.24
- H7R (p.His7Arg), ExAC rs748719517, gnomAD rs748719517, CADD 16.20, PolyPhen-2 0.22
- H7Y (p.His7Tyr), rs140734037, ClinGen CA6904528, ClinVar RCV001537028, ESP rs140734037, CADD 8.92, PolyPhen-2 0.00, Likely benign, not provided
- H7H (p.His7His), rs1869369099, gnomAD 13-20223460-G-A, CADD 4.64
- T8A (p.Thr8Ala), cosmic curated COSV53833, CADD 4.69, PolyPhen-2 0.00
- T8S (p.Thr8Ser), cosmic curated COSV53833, MetaLR 0.83, MetaSVM 0.07
- T8T (p.Thr8Thr), rs992236233, gnomAD 13-20223457-A-C, CADD 0.12
- T8P (p.Thr8Pro), gnomAD 13-20223459-T-G, MetaLR 0.90, MetaSVM 0.67
- F9F (p.Phe9Phe), rs779571160, gnomAD 13-20223454-G-A, CADD 6.78
- F9H (p.Phe9His), gnomAD 13-20223454-GAA-G, CADD 23.60
- I10F (p.Ile10Phe), ExAC rs769071134, gnomAD rs769071134, CADD 17.50, PolyPhen-2 0.37
- I10I (p.Ile10Ile), rs377181573, gnomAD 13-20223451-G-A, CADD 1.67
- I10L (p.Ile10Leu), gnomAD 13-20223453-T-G, MetaLR 0.53, MetaSVM -0.20
- G11E (p.Gly11Glu), TOPMed rs1419669603
- G11R (p.Gly11Arg), rs104894415, UniProt VAR 015696, TOPMed rs104894415, gnomAD rs104894415, CADD 23.60, PolyPhen-2 0.97, Pathogenic, GJB6-related disorder; Inborn genetic diseases; Hidrotic ectodermal dysplasia sy
- G11W (p.Gly11Trp), NCI-TCGA Cosmic COSV5383, cosmic curated COSV53832, Variant assessed as somatic; moderate impact., in ECTD2
- G11G (p.Gly11Gly), rs1869367074, gnomAD 13-20223448-C-T, CADD 3.48
- G12D (p.Gly12Asp), ExAC rs779708708, TOPMed rs779708708, gnomAD rs779708708, CADD 24.20, PolyPhen-2 1.00
- G12V (p.Gly12Val), cosmic curated COSV53833, ExAC rs779708708, TOPMed rs779708708, gnomAD rs779708708, MetaLR 0.98, MetaSVM 1.08
- G12S (p.Gly12Ser), gnomAD 13-20223447-C-T, MetaLR 0.97, MetaSVM 1.10
- V13D (p.Val13Asp), TOPMed rs1869366480, CADD 26.60, PolyPhen-2 0.99, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 1A; Autosomal dominant nonsyndromi
- N14D (p.Asn14Asp), gnomAD rs1257563596, CADD 26.00, PolyPhen-2 0.99
- N14I (p.Asn14Ile), ExAC rs755769938, gnomAD rs755769938, CADD 26.90, PolyPhen-2 1.00
- N14N (p.Asn14Asn), rs372474784, gnomAD 13-20223439-G-A, CADD 9.19
- H16D (p.His16Asp), Ensembl rs1869365402
- H16R (p.His16Arg), cosmic curated COSV53833
- H16Y (p.His16Tyr), NCI-TCGA Cosmic COSV9957, cosmic curated COSV99576, Variant assessed as somatic; moderate impact.
- H16P (p.His16Pro), rs1345877924, gnomAD 13-20223433-GT-G, CADD 29.10
- H16H (p.His16His), rs1869364806, gnomAD 13-20223433-G-A, CADD 9.18
- S17F (p.Ser17Phe), cosmic curated COSV10459, CADD 29.50, PolyPhen-2 1.00
- S17P (p.Ser17Pro), rs2500318596, ClinGen CA387468961, ClinVar RCV002718535, CADD 29.70, PolyPhen-2 0.99, Uncertain significance, Inborn genetic diseases
- S17Y (p.Ser17Tyr), cosmic curated COSV53833, MetaLR 0.99, MetaSVM 1.00
- S17S (p.Ser17Ser), rs1869364239, gnomAD 13-20223430-G-A, CADD 10.10
- S17C (p.Ser17Cys), gnomAD 13-20223431-G-C, MetaLR 0.99, MetaSVM 1.00
- T18I (p.Thr18Ile), cosmic curated COSV53833
- T18N (p.Thr18Asn), NCI-TCGA Cosmic COSV5383, MetaLR 0.99, MetaSVM 1.02, Variant assessed as somatic; moderate impact.
- S19I (p.Ser19Ile), Ensembl rs1869363843
- S19N (p.Ser19Asn), Ensembl rs1869363843, MetaLR 0.96, MetaSVM 1.07
- S19T (p.Ser19Thr), gnomAD 13-20223425-C-G, MetaLR 0.95, MetaSVM 1.06
- I20L (p.Ile20Leu), ExAC rs749915780, TOPMed rs749915780, gnomAD rs749915780, CADD 21.70, PolyPhen-2 0.03
- I20V (p.Ile20Val), ExAC rs749915780, TOPMed rs749915780, gnomAD rs749915780, CADD 21.80
- I20I (p.Ile20Ile), rs778513540, gnomAD 13-20223421-G-A, CADD 7.91
- G21R (p.Gly21Arg), rs751440971, ClinGen CA6904518, ClinVar RCV001757966, ClinVar RCV002488520, CADD 26.70, PolyPhen-2 1.00, Uncertain significance, not provided; Autosomal recessive nonsyndromic hearing loss 1B; Autosomal domina
- G21W (p.Gly21Trp), ExAC rs751440971, TOPMed rs751440971, gnomAD rs751440971, Uncertain significance
- G21G (p.Gly21Gly), rs1555343656, gnomAD 13-20223418-C-T, CADD 10.80
- K22E (p.Lys22Glu), 1000Genomes rs199552278, ExAC rs199552278, CADD 27.70
- K22K (p.Lys22Lys), gnomAD 13-20223415-C-T, CADD 8.95
- K22R (p.Lys22Arg), rs770612890, gnomAD 13-20223417-TC-T, CADD 24.20
- V23L (p.Val23Leu), TOPMed rs1869360890
- V23V (p.Val23Val), rs1869360648, gnomAD 13-20223412-C-T, CADD 6.39
- W24R (p.Trp24Arg), gnomAD 13-20223411-A-G, MetaLR 0.99, MetaSVM 1.00
- I25N (p.Ile25Asn), ExAC rs762699476, gnomAD rs762699476, CADD 26.50, PolyPhen-2 0.60
- I25V (p.Ile25Val), NCI-TCGA TCGA novel, MetaLR 0.90, MetaSVM 0.96, Variant assessed as somatic; moderate impact.
- I25I (p.Ile25Ile), rs1428463920, gnomAD 13-20223406-G-T, CADD 9.36
- I25T (p.Ile25Thr), gnomAD 13-20223407-A-G, MetaLR 0.93, MetaSVM 0.97
- T26T (p.Thr26Thr), rs1342011242, gnomAD 13-20223403-T-A, CADD 0.28
- T26I (p.Thr26Ile), gnomAD 13-20223404-G-A, MetaLR 0.96, MetaSVM 1.13
- V27D (p.Val27Asp), TOPMed rs1300040333, MetaLR 0.99, MetaSVM 1.02
- I28M (p.Ile28Met), gnomAD rs1300641563, CADD 21.40
- I28N (p.Ile28Asn), gnomAD 13-20223398-A-T, MetaLR 0.94, MetaSVM 1.12
- F29I (p.Phe29Ile), Ensembl rs2137334262
- F29S (p.Phe29Ser), NCI-TCGA TCGA novel, MetaLR 0.98, MetaSVM 1.05, Variant assessed as somatic; moderate impact.
- F29C (p.Phe29Cys), gnomAD 13-20223395-A-C, MetaLR 0.98, MetaSVM 1.05
- F29V (p.Phe29Val), gnomAD 13-20223396-A-C, MetaLR 0.97, MetaSVM 1.10
- I30V (p.Ile30Val), NCI-TCGA TCGA novel, MetaLR 0.97, MetaSVM 1.13, Variant assessed as somatic; moderate impact.
- I30T (p.Ile30Thr), gnomAD 13-20223392-A-G, MetaLR 0.98, MetaSVM 1.05
- F31L (p.Phe31Leu), cosmic curated COSV10501, CADD 22.90, PolyPhen-2 1.00
- R32* (p.Arg32Ter), rs577509855, ClinGen CA6904514, cosmic curated COSV53833, ClinVar RCV002721771, CADD 37.00, Uncertain significance
- R32Q (p.Arg32Gln), rs766604251, ClinGen CA6904513, NCI-TCGA Cosmic COSV5383, cosmic curated COSV53832, CADD 26.10, PolyPhen-2 1.00, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 1A; Autosomal dominant nonsyndromi
- R32R (p.Arg32Arg), gnomAD 13-20223385-T-A, CADD 0.70
- V33I (p.Val33Ile), NCI-TCGA Cosmic COSV9957, cosmic curated COSV99576, TOPMed rs1869358311, Variant assessed as somatic; moderate impact.
- M34K (p.Met34Lys), TOPMed rs1869357850
- M34V (p.Met34Val), cosmic curated COSV53833, MetaLR 0.78, MetaSVM 0.35
- M34T (p.Met34Thr), gnomAD 13-20223380-A-G, MetaLR 0.94, MetaSVM 1.16
- I35F (p.Ile35Phe), NCI-TCGA Cosmic COSV9957, cosmic curated COSV99576, Variant assessed as somatic; moderate impact.
- I35M (p.Ile35Met), ExAC rs773325500, TOPMed rs773325500, gnomAD rs773325500, CADD 23.10, PolyPhen-2 0.99
- I35I (p.Ile35Ile), rs773325500, gnomAD 13-20223376-G-A, CADD 8.00
- I35V (p.Ile35Val), gnomAD 13-20223378-T-C, MetaLR 0.76, MetaSVM 0.44
- L36L (p.Leu36Leu), gnomAD 13-20223373-G-T, CADD 0.36
- L36P (p.Leu36Pro), gnomAD 13-20223374-A-G, MetaLR 0.98, MetaSVM 1.07
- V37E (p.Val37Glu), rs104894416, ClinGen CA253530, ClinVar RCV000005886, UniProt VAR 016838, CADD 24.50, PolyPhen-2 1.00, Pathogenic, Hidrotic ectodermal dysplasia syndrome
- V37L (p.Val37Leu), ExAC rs761985641, TOPMed rs761985641, gnomAD rs761985641, Uncertain significance, in ECTD2
- V37M (p.Val37Met), rs761985641, ClinGen CA6904509, NCI-TCGA Cosmic COSV5383, cosmic curated COSV53833, CADD 22.90, PolyPhen-2 1.00, Uncertain significance, Hidrotic ectodermal dysplasia syndrome; Autosomal recessive nonsyndromic hearing
- V37V (p.Val37Val), rs543659673, gnomAD 13-20223370-C-T, CADD 1.22
- V38G (p.Val38Gly), ExAC rs769308126, TOPMed rs769308126, gnomAD rs769308126, CADD 25.10, PolyPhen-2 0.95
- V38L (p.Val38Leu), gnomAD 13-20223369-C-A, MetaLR 0.92, MetaSVM 0.89
- A39D (p.Ala39Asp), TOPMed rs1369386944, gnomAD rs1369386944, CADD 24.50, PolyPhen-2 1.00
- A39P (p.Ala39Pro), gnomAD rs1473999879, CADD 24.30, PolyPhen-2 1.00
- A39A (p.Ala39Ala), rs727503070, gnomAD 13-20223364-A-G, CADD 0.28
- A39T (p.Ala39Thr), gnomAD 13-20223366-C-T, MetaLR 0.98, MetaSVM 1.09
- A40V (p.Ala40Val), rs780320724, ClinGen CA6904506, ClinVar RCV000487477, ClinVar RCV001856883, CADD 24.80, PolyPhen-2 0.98, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 3B; Autosomal recessive nonsyndromi
- A40A (p.Ala40Ala), rs769484704, gnomAD 13-20223361-G-A, CADD 0.95
- A40T (p.Ala40Thr), gnomAD 13-20223363-C-T, MetaLR 0.97, MetaSVM 1.10
- Q41E (p.Gln41Glu), Ensembl rs1869354077, CADD 9.87, PolyPhen-2 0.00
- Q41R (p.Gln41Arg), gnomAD 13-20223359-T-C, MetaLR 0.89, MetaSVM 0.84
- Q41* (p.Gln41Ter), gnomAD 13-20223360-G-A, CADD 35.00
- E42D (p.Glu42Asp), gnomAD 13-20223355-T-A, MetaLR 0.84, MetaSVM 0.36
- V43A (p.Val43Ala), Ensembl rs968737561, MetaLR 0.98, MetaSVM 1.09
- V43M (p.Val43Met), cosmic curated COSV99575, CADD 24.20, PolyPhen-2 1.00
- V43V (p.Val43Val), rs368228976, gnomAD 13-20223352-C-T, CADD 4.82
- V43E (p.Val43Glu), gnomAD 13-20223353-A-T, MetaLR 0.99, MetaSVM 1.01
- W44* (p.Trp44Ter), ExAC rs780836560, gnomAD rs780836560, CADD 36.00
- W44C (p.Trp44Cys), ExAC rs780836560, gnomAD rs780836560, CADD 25.40, PolyPhen-2 1.00
- W44X, rs780836560, []
- G45S (p.Gly45Ser), ExAC rs756689586, gnomAD rs756689586, CADD 23.00, PolyPhen-2 1.00
- G45V (p.Gly45Val), NCI-TCGA TCGA novel, CADD 24.10, PolyPhen-2 1.00, Variant assessed as somatic; high impact.
- G45C (p.Gly45Cys), gnomAD 13-20223348-C-A, MetaLR 0.98, MetaSVM 1.05
- D46D (p.Asp46Asp), rs748793847, gnomAD 13-20223343-G-A, CADD 0.12
- D46H (p.Asp46His), gnomAD 13-20223345-C-G, MetaLR 0.99, MetaSVM 1.00
- E47K (p.Glu47Lys), cosmic curated COSV53832, gnomAD rs1869352027, CADD 24.60, PolyPhen-2 1.00
- E47E (p.Glu47Glu), gnomAD 13-20223340-C-T, CADD 1.18
- Q48K (p.Gln48Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E49E (p.Glu49Glu), rs374808795, gnomAD 13-20223334-C-T, CADD 0.68
- D50G (p.Asp50Gly), Ensembl rs536922608, CADD 22.80, PolyPhen-2 0.14
- D50H (p.Asp50His), rs1869351345, ClinGen CA387468745, ClinVar RCV001267508, ClinVar RCV003985842, Likely pathogenic, Hidrotic ectodermal dysplasia syndrome; Inborn genetic diseases
- D50N (p.Asp50Asn), Ensembl rs1869351345, MetaLR 0.90, MetaSVM 0.69, Likely pathogenic
- D50D (p.Asp50Asp), gnomAD 13-20223331-G-A, CADD 6.02
- F51F (p.Phe51Phe), rs185764408, gnomAD 13-20223328-G-A, CADD 0.33
- V52F (p.Val52Phe), rs143410202, ClinGen CA387468729, ClinVar RCV003788975, ClinVar RCV006368592, CADD 22.70, PolyPhen-2 0.80, Uncertain significance, Inborn genetic diseases; Autosomal dominant nonsyndromic hearing loss 3B; Autoso
- V52I (p.Val52Ile), cosmic curated COSV53832, ESP rs143410202, ExAC rs143410202, TOPMed rs143410202, CADD 13.30, PolyPhen-2 0.00, Uncertain significance
- p.Val52 Cys53insSer, gnomAD 13-20223323-C-CAA, CADD 18.20
- C53* (p.Cys53Ter), rs2500317080, ClinGen CA387468719, ClinVar RCV002302535, Uncertain significance
- C53F (p.Cys53Phe), gnomAD 13-20223323-C-A, MetaLR 0.99, MetaSVM 0.96
- p.Thr55 Leu56delinsMet, gnomAD 13-20223314-AGTG-, CADD 19.40
- T55T (p.Thr55Thr), rs1175349695, gnomAD 13-20223316-T-C, CADD 0.47
- T55R (p.Thr55Arg), gnomAD 13-20223318-T-TCC, CADD 28.00
- T55A (p.Thr55Ala), gnomAD 13-20223318-T-C, MetaLR 0.98, MetaSVM 1.04
- L56L (p.Leu56Leu), gnomAD 13-20223313-C-T, CADD 8.95
- Q57* (p.Gln57Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P58L (p.Pro58Leu), rs764997003, ClinGen CA6904497, ClinVar RCV003287499, ClinVar RCV005636893, CADD 27.00, PolyPhen-2 0.96, Uncertain significance, Inborn genetic diseases; not provided; Autosomal dominant nonsyndromic hearing l
- P58P (p.Pro58Pro), rs1309757111, gnomAD 13-20223307-C-T, CADD 0.32
- G59E (p.Gly59Glu), rs2137333887, ClinGen CA387468682, ClinVar RCV001553381, Ensembl rs2137333887, Likely pathogenic, not provided
- G59R (p.Gly59Arg), UniProt VAR 057960, Uncertain significance, found in one patient with a syndrome resembling Vohwinkel and Bart-Pumphrey synd
- G59V (p.Gly59Val), rs2137333887, ClinGen CA387468680, ClinVar RCV002300270, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 3B; Autosomal recessive nonsyndromi
- G59G (p.Gly59Gly), rs371123633, gnomAD 13-20223304-T-C, CADD 0.95
- C60F (p.Cys60Phe), rs750540794, ClinGen CA6904496, ClinVar RCV000489805, ClinVar RCV000765116, CADD 25.60, PolyPhen-2 1.00, Uncertain significance, not provided; Autosomal recessive nonsyndromic hearing loss 1A; Autosomal domina
- C60C (p.Cys60Cys), gnomAD 13-20223301-G-A, CADD 10.00
- C60W (p.Cys60Trp), gnomAD 13-20223301-G-C, MetaLR 0.99, MetaSVM 1.01
- K61Q (p.Lys61Gln), NCI-TCGA TCGA novel, MetaLR 0.82, MetaSVM 0.06, Variant assessed as somatic; moderate impact.
- N62S (p.Asn62Ser), cosmic curated COSV10727, CADD 21.80, PolyPhen-2 0.38
- p.Asn62 Val63delinsMet, gnomAD 13-20223293-ACAT-, CADD 17.90
- N62N (p.Asn62Asn), rs1382718453, gnomAD 13-20223295-A-G, CADD 1.43
- V63M (p.Val63Met), TOPMed rs1355233247, gnomAD rs1355233247, CADD 25.00
- V63V (p.Val63Val), rs2137333821, gnomAD 13-20223292-C-T, CADD 3.90
- C64* (p.Cys64Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C64C (p.Cys64Cys), gnomAD 13-20223289-G-A, CADD 9.35
- Y65* (p.Tyr65Ter), gnomAD 13-20223286-A-T, CADD 26.30
- D66N (p.Asp66Asn), Ensembl rs1001822002, MetaLR 0.99, MetaSVM 1.07
- D66Y (p.Asp66Tyr), gnomAD 13-20223285-C-A, MetaLR 0.99, MetaSVM 1.00
- H67N (p.His67Asn), cosmic curated COSV99576
- H67Q (p.His67Gln), 1000Genomes rs554688212, ExAC rs554688212, TOPMed rs554688212, gnomAD rs554688212, CADD 20.90, PolyPhen-2 0.08
- H67H (p.His67His), gnomAD 13-20223280-G-A, CADD 8.96
- H67D (p.His67Asp), gnomAD 13-20223282-G-C, MetaLR 0.96, MetaSVM 1.06
- F68I (p.Phe68Ile), NCI-TCGA Cosmic COSV5383, cosmic curated COSV53831, TOPMed rs1869347003, MetaLR 0.96, MetaSVM 1.05, Variant assessed as somatic; moderate impact.
- F69S (p.Phe69Ser), NCI-TCGA Cosmic COSV5383, cosmic curated COSV53832, MetaLR 0.98, MetaSVM 1.03, Variant assessed as somatic; moderate impact.
- F69F (p.Phe69Phe), rs1390955098, gnomAD 13-20223274-G-A, CADD 10.20
- P70L (p.Pro70Leu), rs727505123, ClinGen CA185121, ClinVar RCV000156580, ClinVar RCV000404790, CADD 27.30, PolyPhen-2 1.00, Uncertain significance, not specified; GJB6-related disorder; not provided
- P70P (p.Pro70Pro), rs575963681, gnomAD 13-20223271-C-T, CADD 0.27
- V71A (p.Val71Ala), rs200172266, ClinGen CA6904492, ClinVar RCV001110826, ClinVar RCV001563386, CADD 26.10, PolyPhen-2 0.85, Conflicting interpretations, Hidrotic ectodermal dysplasia syndrome; Autosomal recessive nonsyndromic hearing
- V71V (p.Val71Val), rs1183496095, gnomAD 13-20223268-C-T, CADD 8.00
- V71L (p.Val71Leu), gnomAD 13-20223270-C-G, MetaLR 0.92, MetaSVM 0.94
- S72F (p.Ser72Phe), rs763435578, ClinGen CA6904491, ClinVar RCV001756899, ClinVar RCV004741069, CADD 29.40, PolyPhen-2 1.00, Uncertain significance, not provided; Inborn genetic diseases
- H73P (p.His73Pro), Ensembl rs1869344946
- H73Q (p.His73Gln), cosmic curated COSV53832, MetaLR 0.99, MetaSVM 1.03
- H73H (p.His73His), gnomAD 13-20223262-G-A, CADD 10.30
- H73Y (p.His73Tyr), gnomAD 13-20223264-G-A, MetaLR 0.99, MetaSVM 1.02
- I74S (p.Ile74Ser), cosmic curated COSV10878, MetaLR 0.98, MetaSVM 1.06
- R75Q (p.Arg75Gln), cosmic curated COSV10727, ExAC rs775911480, TOPMed rs775911480, gnomAD rs775911480, CADD 28.90, PolyPhen-2 1.00, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 1A; Autosomal dominant nonsyndromi
- R75W (p.Arg75Trp), rs2137333664, ClinGen CA387468573, NCI-TCGA Cosmic COSV1043, cosmic curated COSV10438, CADD 27.60, PolyPhen-2 1.00, Conflicting interpretations, Autosomal recessive nonsyndromic hearing loss 1B; Autosomal dominant nonsyndromi
Public GJB6 analysis runs
- GJB6 analysis run — GJB6 (639 variants) — completed 2026-08-21